Table 1.
Baseline Patient Demographics, Clinical Characteristics, Treatments, and Outcomes
| Characteristic | N = 892 |
|---|---|
| Age, y | 59 (47–72) |
| Sex | |
| Female | 358 (40.1%) |
| Race/ethnicity | |
| African American | 57 (6.4%) |
| Asian | 127 (14.2%) |
| Hispanic or Latino | 409 (45.9%) |
| White | 167 (18.7%) |
| Other | 85 (9.5%) |
| Not available | 45 (5.0%) |
| Comorbidities | |
| Hypertension | 397 (44.5%) |
| Diabetes | 245 (27.5%) |
| Cardiac disease | 185 (20.7%) |
| Renal disease | 89 (10.0%) |
| Pulmonary disease | 113 (12.7%) |
| Hepatic disease | 19 (2.1%) |
| GI symptoms | |
| Loss of taste | 21 (2.4%) |
| Loss of appetite | 105 (11.8%) |
| Abdominal pain | 70 (7.8%) |
| Nausea | 148 (16.6%) |
| Vomiting | 91 (10.2%) |
| Diarrhea | 177 (19.8%) |
| Any GI symptom | 219 (24.6%) |
| Duration of symptoms, d | 4 (3–7) (number available, 251) |
| Treatment | |
| Hydroxychloroquine | 726 (81.4%) |
| Azithromycin | 770 (86.3%) |
| Tocilizumab | 12 (1.3%) |
| Remdesivir | 9 (1.0%) |
| Outcome | |
| ICU admission | 131 (14.7%) |
| Intubation | 136 (15.2%) |
| Length of stay, d | 6 (3–10) (number available, 876) |
| Mortality | 215 (24.1%) |
NOTE. Data are presented as n (%) or as median (interquartile range).
GI, gastrointestinal; ICU, intensive care unit.